GlaxoSmithKline (GSK) commits $1 million in cervical cancer vaccine to new cooperative effort aimed at reducing deaths from women's cancers

Abstract:

GlaxoSmithKline (GSK) today announced that it has committed $1 million in Cervarix® cervical cancer vaccine to the Pink Ribbon Red Ribbon partnership over the next five years. GSK has also pledged $50,000 to support the program operations. As a result of this donation, more than 10,000 girls and women will have access to vaccination

Año de publicación:

Keywords:

Fuente:

google